The Global Veterinary Vaccines Market is expected to grow at a CAGR of 6.2% to reach $8.6 billion by 2022. The factors driving the veterinary vaccines market include rising zoonotic diseases, growing incidence of animal diseases, increasing investments by government and welfare associations. However, factors such as increasing adoption of vegetarian food in prominent economies and increasing costs of storage and maintenance of vaccines are hindering the market growth. Growing awareness of animal health in emerging economies and technological innovations are likely to create opportunities for veterinary vaccines market in the coming years.
The Global veterinary vaccines market is segmented on the basis of diseases, technologies and geography. On the basis of diseases, the veterinary vaccine market is segmented into companion animal diseases (respiratory, gastrointestinal and reproductive tracts), poultry diseases (bronchitis, avian influenza, newcastle disease and marek’s disease), porcine diseases (porcine reproductive disease, swine pneumonia and swine influenza) and equine diseases (rhinopneumonitis, influenza and encephalomyelitis). By technologies, the market is categorized into toxoid vaccines, DNA vaccines, recombinant vaccines, live attenuated vaccines (LAV) and inactivated vaccines. By geography, it is segmented into North America, Europe, Asia Pacific and Rest of the World. European region is known to be a leading veterinary vaccine market in terms of consumption, closely followed by the U.S. However, Asia is expected to register a higher growth rate during the forecast period owing to huge investment opportunities in this region.
Some of the key players in the veterinary vaccine market include Zoetis (U.S.), Merck Animal Health (U.S.), Merial Inc. (Sanofi) (France), Elanco Animal Health (U.S.)., Boehringer Ingelheim (Germany), Bayer Healthcare (Germany), Bioniche Animal Health (Canada), Heska Co. (U.S.), Ceva Animal Health, Inc. and Virbac.
The report on the global Veterinary Vaccines market divides the market into different region-based segments according to the regions that each one is located in. The major regions that are covered in the market report include North America, South America, Asia-Pacific, the Middle East, Europe, and Africa. The market share of Veterinary Vaccines in these regions is calculated and is presented in the report. This data is collected according to a variety of different parameters that are chosen to present the most accurate data and the status of the different regions. The report includes the data for the review year 2019 to 2025 and the data is forecast from the year 2019 to 2025. The Veterinary Vaccines market report also segments the market based on products/services and end-user/applications.
What our report offers:
– Market share assessments for the regional and country level segments
– Market share analysis of the top industry players
– Strategic recommendations for the new entrants
– Market forecasts for a minimum of 8 years of all the mentioned segments, sub segments and the regional markets
– Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
– Strategic recommendations in key business segments based on the market estimations
– Competitive landscaping mapping the key common trends
– Company profiling with detailed strategies, financials, and recent developments
– Supply chain trends mapping the latest technological advancements
Table of Content
1 Executive Summary
2.2 Research Scope
2.3 Research Methodology
2.4 Research Sources
3 Market Trend Analysis
4 Porters Five Force Analysis
4.1 Bargaining power of suppliers
4.2 Bargaining power of buyers
4.3 Threat of substitutes
4.4 Threat of new entrants
4.5 Competitive rivalry
5 Global Veterinary Vaccines Market, By Diseases
6 Global Veterinary Vaccines Market, By Technologies
7 Global Veterinary Vaccines Market, By Geography
8 Key Developments
9 Company Profiling
9.1 Zoetis (U.S.)
9.2 Merck Animal Health (U.S.)
9.3 Merial Inc. (Sanofi) (France)
9.4 Elanco Animal Health (U.S.).
9.5 Boehringer Ingelheim (Germany)
9.6 Bayer Healthcare (Germany)
9.7 Bioniche Animal Health (Canada)
9.8 Heska Co. (U.S.)
9.9 Ceva Animal Health, Inc.
Contact Us: Sales@Wiseguyreports.Com Ph: +1-646-845-9349 (Us) Ph: +44 208 133 9349 (Uk)